GC Biopharma Corp. (KRX:006280)
127,200
+1,900 (1.52%)
At close: May 30, 2025, 3:30 PM KST
GC Biopharma Revenue
GC Biopharma had revenue of 383.78B KRW in the quarter ending March 31, 2025, with 7.56% growth. This brings the company's revenue in the last twelve months to 1.71T, up 4.46% year-over-year. In the year 2024, GC Biopharma had annual revenue of 1.68T with 3.27% growth.
Revenue (ttm)
1,706.86B
Revenue Growth
+4.46%
P/S Ratio
0.85
Revenue / Employee
849.61M
Employees
2,009
Market Cap
1,451.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,679.89B | 53.25B | 3.27% |
Dec 31, 2023 | 1,626.64B | -84.67B | -4.95% |
Dec 31, 2022 | 1,711.31B | 173.49B | 11.28% |
Dec 31, 2021 | 1,537.83B | 33.71B | 2.24% |
Dec 31, 2020 | 1,504.12B | 147.00B | 10.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 4.30B |
PharmaResearch | 392.31B |